Latest News & Features
article
Case concerns epilepsy drug patent and medical cannabis R&D collaboration | Dispute between Japanese and Irish pharma firms will be heard in London due to arbitration carve-out clause. 10 November 2022
Big Pharma
Dispute over patent relating to a CAR-T cell therapy shunned by top court | Backing from Amgen, GSK and St. Jude's Children's Research Hospital over “exceedingly narrow” patent protection fails to convince Justices. 10 November 2022
article
Spruson & Ferguson has hired litigator Katrina Crooks as a principal, who will join its office in Sydney. 8 November 2022
article
Humanitarian organisations censure leaked IP provisions within UK-India free trade agreement | “Excessive measures” would “drastically harm access” to affordable, lifesaving generic medicines from India. 8 November 2022
Americas
The dispute centres on a section of the Patent Act concerning 'enablement' | The US government had urged the court to deny the petition. 7 November 2022
article
Counsel for Ventria sat down with Sarah Speight to explore their landmark win at the International Trade Commission, which led to a US ban for a Chinese company 3 November 2022
article
Patent law firm EIP has hired Pontus Falk as a partner at its recently opened Sweden office. 3 November 2022
Big Pharma
Cardiovascular ‘innovator’ snapped up as company strengthens medtech offering | Massachusetts-based Abiomed will become part of purchaser’s medtech division 2 November 2022
Generics
Agreement is 'first ever' public health focused voluntary licensing deal on a cancer medicine| Opportunities for generic manufacturers 1 November 2022
Big Pharma
The temporary injunction prevents a Pfizer unit from launching a generic| The dispute centres on a branded coronary artery test 1 November 2022